Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania

18 pages, Oct 2017

US$990

Add to cart Pay by invoice

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

Executive Summary

New Report Guarantee

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!

PROSPECTS

Positive outlook for cough, cold and allergy (hay fever) remedies

The forecast period is expected to see cough, cold and allergy (hay fever) remedies generate a 2% value CAGR at constant 2017 prices, with annual sales reaching EUR35 million by 2022. Nevertheless, growth rates in the category are set to be considerably slower than what was recorded over the review period and this is likely to be due mainly to the category’s maturity, which is making it increasingly difficult to sustain strong growth, especially as Lithuania is a small country with a modest population.

Pace of growth are set to be steady rather than spectacular

During the forecast period, the pace of development in cough, cold and allergy (hay fever) remedies is expected to be stable and steady rather than dramatic or spectacular. Demand for these products is already quite mature as Lithuanian people tend to be quite conservative when it comes to purchasing OTC remedies for coughs, colds and allergies.

Few changes, if any, expected in the competitive landscape

The competitive landscape in cough, cold and allergy (hay fever) remedies is unlikely to see any major changes during the forecast period. The brands which have traditionally been the most popular in the category are expected to continue attracting the attention of consumers as they are known for being effective as well as trusted.

COMPETITIVE LANDSCAPE

International players maintain dominance

International companies continue to dominate sales in cough, cold and allergy (hay fever) remedies, with GSK Consumer Healthcare the outright leader in 2017 with a 22% value share, followed by Johnson & Johnson with 11%. Proven effectiveness is the main driver of demand in the category and GSK benefits from the strong reputations of its several very well-known brands in the category, including Theraflu, Otrivin, Tavegyl and ACC.

Domestic companies continue to struggle

Local players continued to lose ground in cough, cold and allergy (hay fever) remedies in 2017. The leading local player in the category is Valentis, which offers the Miramile and Pertusinas brands, each of which is very familiar to Lithuanian consumers.

Branded products continue to benefit from consumer preference for strong names

Sales of private label and generic products remain underdeveloped in cough, cold and allergy (hay fever) remedies. Generally speaking, Lithuanian consumers pay little attention to private label or generic products as they often regard such products as less effective than branded equivalents.

Files are delivered directly into your account within a few minutes of purchase.

Samples

Cough, Cold and Allergy Sample Report Cough, Cold and Allergy Sample Data

Overview

Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Lithuania, our research will save you time and money while empowering you to make informed, profitable decisions.

The Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania market research report includes:

Analysis of key supply-side and demand trends
Detailed segmentation of international and local products
Historic volumes and values, company and brand market shares
Five year forecasts of market trends and market growth
Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania?
What are the major brands in Lithuania?
What is the impact of influenza vaccinations on the sales of cough and cold products?

Why buy this report?

Gain competitive intelligence about market leaders
Track key industry trends, opportunities and threats
Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Want to find out more about this report?

Request more information

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania - Category analysis

HEADLINES

PROSPECTS

Positive outlook for cough, cold and allergy (hay fever) remedies

Pace of growth are set to be steady rather than spectacular

Few changes, if any, expected in the competitive landscape

COMPETITIVE LANDSCAPE

International players maintain dominance

Domestic companies continue to struggle

Branded products continue to benefit from consumer preference for strong names

CATEGORY DATA

Table 1 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2012-2017
Table 2 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2012-2017
Table 3 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2013-2017
Table 4 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2014-2017
Table 5 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
Table 6 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022

Consumer Health in Lithuania - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to benefit from the improving economic situation

Growth underpinned by the health and wellness trend and rising self-medication

The importance of private label continues to increase

Discounters becomes the most dynamic distribution channel for consumer health

Rising demand set to be based on economic stability and the self-medication trend

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
Table 8 Life Expectancy at Birth 2012-2017

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2012-2017
Table 10 Sales of Consumer Health by Category: % Value Growth 2012-2017
Table 11 NBO Company Shares of Consumer Health: % Value 2013-2017
Table 12 LBN Brand Shares of Consumer Health: % Value 2014-2017
Table 13 Penetration of Private Label by Category: % Value 2012-2017
Table 14 Distribution of Consumer Health by Format: % Value 2012-2017
Table 15 Distribution of Consumer Health by Format and Category: % Value 2017
Table 16 Forecast Sales of Consumer Health by Category: Value 2017-2022
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022

Megatrends

Country Report

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania

New Report Guarantee

Executive Summary

New Report Guarantee

PROSPECTS

Positive outlook for cough, cold and allergy (hay fever) remedies

Pace of growth are set to be steady rather than spectacular

Few changes, if any, expected in the competitive landscape

COMPETITIVE LANDSCAPE

International players maintain dominance

Domestic companies continue to struggle

Branded products continue to benefit from consumer preference for strong names

Samples

Overview

Why buy this report?

Samples (FAQs about samples):

Want to find out more about this report?

Table of Contents

Cough, Cold and Allergy (Hay Fever) Remedies in Lithuania - Category analysis

HEADLINES

PROSPECTS

Positive outlook for cough, cold and allergy (hay fever) remedies

Pace of growth are set to be steady rather than spectacular

Few changes, if any, expected in the competitive landscape

COMPETITIVE LANDSCAPE

International players maintain dominance

Domestic companies continue to struggle

Branded products continue to benefit from consumer preference for strong names

CATEGORY DATA

Consumer Health in Lithuania - Industry Overview

EXECUTIVE SUMMARY

Consumer health continues to benefit from the improving economic situation

Growth underpinned by the health and wellness trend and rising self-medication

The importance of private label continues to increase

Discounters becomes the most dynamic distribution channel for consumer health

Rising demand set to be based on economic stability and the self-medication trend

MARKET INDICATORS

MARKET DATA

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventive medicine

Switches

SOURCES

Why buy this report?

Want to find out more about this report?

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports

Recently Viewed

Complete Catalogue

Country Reports

Strategy Reports